The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Prolactin and dopamine: What is the connection? A Review Article
Abstract
Dopamine (DA) holds a predominant role in the regulation of prolactin (PRL) secretion. Through a direct effect on anterior pituitary lactotrophs, DA inhibits the basally high-secretory tone of the cell. It accomplishes this by binding to D2 receptors expressed on the cell membrane of the lactotroph, activation of which results in a reduction of PRL exocytosis and gene expression by a variety of intracellular signalling mechanisms. The hypothalamic dopaminergic neurons, which provide DA to the anterior pituitary gland, are themselves regulated by feedback from PRL through a short-loop feedback mechanism . A variety of other modulators of prolactin secretion act at the hypothalamic level by either disinhibition of the dopaminergic tone (e.g. serotonin, GABA, oestrogens and opioids) or by reinforcing it (e.g. substance P). All typical antipsychotic medications are associated with sustained hyperprolactinaemia due to their high affinity for the D2 receptor and their slow dissociation from the receptor once bound, but atypicals differ quite dramatically in their propensity to cause prolonged high prolactin levels. Of those atypicals that are associated with prolactin elevation, the main causative factor appears to be a higher peripheral-to-central dopamine receptor potency of either the parent drug or its active metabolite (e.g. risperidone, 9-hydroxy-risperidone and amisulpride). Antipsychotics that easily cross the blood—brain barrier and exhibit fast dissociation from the dopamine receptor once bound do not result in sustained hyperprolactinaemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457 · cited 14×
“Its predominant site of action, however, remains the hypothalamus where several serotonin receptor types have been found to play a role in its effect on PRL secretion, including the 1A, 2A and 2C subtypes (Freeman et al., 2000).”
BackgroundInfluentialStructural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., & Kelly, P. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0334 · Cited by 1,938
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Stat5a is mandatory for adult mammary gland development and lactogenesis.
Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., & Hennighausen, L. (1997) · Genes & Development · doi:10.1101/gad.11.2.179 · Cited by 1,111
Kapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.514 · Cited by 1,090
Dopamine as a Prolactin (PRL) Inhibitor
Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983 · cited 4×
“, 1995) The tuberoinfundibular dopaminergic (TIDA) neuronal population, the cell bodies of which reside in the arcuate nucleus, is the most important in regulating PRL release in humans (Leong et al., 1983; Ben-Jonathan and Hnasko, 2001).”
BackgroundInfluentialAtypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.457 · Cited by 891
The Prolactin/Growth Hormone Receptor Family
KELLY, P. A., DJIANE, J., POSTEL-VINAY, M.-C., & EDERY, M. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-3-235 · Cited by 727
Maggio, J. E. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000305 · Cited by 547
Quetiapine in Patients With Schizophrenia: A High- and Low-Dose Double-blind Comparison With Placebo
Small, J. G. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180067009 · Cited by 478
THE PREPARATION, IDENTIFICATION AND ASSAY OF PROLACTIN—A HORMONE OF THE ANTERIOR PITUITARY
Riddle, O., Bates, R. W., & Dykshorn, S. W. (1933) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1933.105.1.191 · Cited by 478
Kapur, S. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.6.553 · Cited by 396
Caron, M. G., Beaulieu, M., Raymond, V., Gagné, B., Drouin, J., Lefkowitz, R. J., & Labrie, F. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38065-1 · Cited by 383
Potent Antidopaminergic Activity of Estradiol at the Pituitary Level on Prolactin Release
Raymond, V., Beaulieu, M., Labrie, F., & Boissier, J. (1978) · Science · doi:10.1126/science.418505 · Cited by 380
The Comparative Endocrinology of Prolactin
BERN, H. A., & NICOLL, C. S. (1968) · Proceedings of the 1967 Laurentian Hormone Conference · doi:10.1016/b978-1-4831-9827-9.50019-8 · Cited by 377
Regulation of prolactin secretion at the level of the lactotroph
Lamberts, S. W., & Macleod, R. M. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.279 · Cited by 353
Human prolactin. cDNA structural analysis and evolutionary comparisons.
Cooke, N. E., Coit, D., Shine, J., Baxter, J. D., & Martial, J. A. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69558-x · Cited by 334
Neuroendocrine Control of Prolactin Secretion
Leong, D. A., Frawley, L. S., & Neill, J. D. (1983) · Annual Review of Physiology · doi:10.1146/annurev.ph.45.030183.000545 · Cited by 304
Tolerability of Atypical Antipsychotics
Stanniland, C., & Taylor, D. (2000) · Drug Safety · doi:10.2165/00002018-200022030-00004 · Cited by 303
Enjalbert, A., & Bockaert, J. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14305-8 · Cited by 262
HORSEMAN, N. D., & YU-LEE, L.-Y. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-627 · Cited by 224
Prolactin-Like Immunoreactivity: Localization in Nerve Terminals of Rat Hypothalamus
Fuxe, K., Hökfelt, T., Eneroth, P., Gustafsson, J.-Å., & Skett, P. (1977) · Science · doi:10.1126/science.323973 · Cited by 194
Elevation of Prolactin Levels by Atypical Antipsychotics
Turrone, P., Kapur, S., Seeman, M. V., & Flint, A. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.133 · Cited by 190
Prolactin: Physiological Actions of Prolactin
Cowie, A. T. (1973) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577306600912 · Cited by 186
Berwaer, M., MARTIAL, J. A., & Davis, J. R. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.5.8058071 · Cited by 172
The Prolactin Gene Is Located on Chromosome 6 iIn Humans
Owerbach, D., Rutter, W. J., Cooke, N. E., Martial, J. A., & Shows, T. B. (1981) · Science · doi:10.1126/science.7221563 · Cited by 164
MacLeod, R. M., Fontham, H., & Pace, R. C. (1969) · Endocrinology · doi:10.1210/endo-85-5-916 · Cited by 160
Kapur, S., Langlois, X., Vinken, P., Megens, A. A. H. P., De Coster, R., & Andrews, J. S. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035303 · Cited by 158
MacLeod, R. M., Fontham, E. H., & Lehmeyer, J. E. (2008) · Neuroendocrinology · doi:10.1159/000121933 · Cited by 155
Predominant Role of the 9-Hydroxy Metabolite of Risperidone in Elevating Blood Prolactin Levels
Knegtering, R., Baselmans, P., Castelein, S., Bosker, F. J., Bruggeman, R., & van den Bosch, R. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.1010 · Cited by 150
Kawano, H., & Daikoku, S. (1987) · The Journal of Comparative Neurology · doi:10.1002/cne.902650208 · Cited by 143
HUMAN PITUITARY PROLACTIN (hPRL): THE ENTIRE LINEAR AMINO ACID SEQUENCE
Shome, B., & Parlow, A. F. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1112 · Cited by 143
Arbogast, L. A., & Voogt, J. L. (1991) · Endocrinology · doi:10.1210/endo-128-2-997 · Cited by 142
Estrogen Inhibition of Dopamine Release into Hypophysial Portal Blood*
Cramer, O. M., Parker, R. C., & Porter, J. C. (1979) · Endocrinology · doi:10.1210/endo-104-2-419 · Cited by 133
Goudreau, J. L., Lindley, S. E., Lookingland, K. J., & Moore, K. E. (2008) · Neuroendocrinology · doi:10.1159/000126214 · Cited by 130
Antipsychotic drugs stimulate prolactin release
Clemens, J. A., Smalstig, E. B., & Sawyer, B. D. (1974) · Psychopharmacology · doi:10.1007/bf00421361 · Cited by 122
Signaling via JAK tyrosine kinases: growth hormone receptor as a model system.
Carter‐Su, C., & Smit, L. S. (1998) · PubMed · Cited by 121
From Galactorrhea to Osteopenia: Rethinking Serotonin–Prolactin Interactions
Emiliano, A. B., & Fudge, J. L. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300412 · Cited by 117
Cooke, P. S., Holsberger, D. R., Witorsch, R. J., Sylvester, P. W., Meredith, J. M., Treinen, K. A., & Chapin, R. E. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.09.016 · Cited by 115
Rossier, J., French, E. D., RIVIER, C. L., Shibasaki, T., Guillemin, R., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.666 · Cited by 111
Pi, X., & Grattan, D. R. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00109-0 · Cited by 109
Clozapine: New research on efficacy and mechanism of action
Meltzer, H. Y., Bastani, B., Ramirez, L. F., & Matsubara, S. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00449814 · Cited by 106
MONOAMINES AND THE PITUITARY GLAND
Dahlström, A. B., & Fuxé, K. (1966) · European Journal of Endocrinology · doi:10.1530/acta.0.0510301 · Cited by 105
Israël, J. M., Kirk, C. J., & Vincent, J. D. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016682 · Cited by 100
Functional Variations among Prolactin Cells from Different Pituitary Regions*
Boockfor, F. R., & Frawley, L. S. (1987) · Endocrinology · doi:10.1210/endo-120-3-874 · Cited by 99
Prolactin enhancement of its own uptake at the choroid plexus
Mangurian, L. P., Walsh, R. J., & Posner, B. I. (1992) · Endocrinology · doi:10.1210/endo.131.2.1639017 · Cited by 93
Goudreau, J. L., Falls, W. M., Lookingland, K. J., & Moore, K. E. (2008) · Neuroendocrinology · doi:10.1159/000126999 · Cited by 89
Ma, F. Y., Anderson, G. M., Gunn, T. D., Goffin, V., Grattan, D. R., & Bunn, S. J. (2005) · Endocrinology · doi:10.1210/en.2005-0770 · Cited by 87
Distribution and Partial Characterization of Immunoreactive Prolactin in the Rat Brain
Harlan, R. E., Shivers, B. D., Fox, S. R., Kaplove, K. A., Schachter, B. S., & Pfaff, D. W. (2008) · Neuroendocrinology · doi:10.1159/000125085 · Cited by 86
DeVito, W. J. (2008) · Neuroendocrinology · doi:10.1159/000124926 · Cited by 85
Clozapine: Plasma levels and prolactin response
Kane, J. M., Cooper, T. B., Sachar, E. J., Halpern, F. S., & Bailine, S. H. (1981) · Psychopharmacology · doi:10.1007/bf00429215 · Cited by 81
Arbogast, L. A., & Voogt, J. L. (1997) · Endocrinology · doi:10.1210/endo.138.7.5227 · Cited by 76
Bagdy, G., & Makara, G. B. (1994) · Endocrinology · doi:10.1210/endo.134.3.8119151 · Cited by 74
Possible Role of Cyclic AMP and Prostaglandin E1in the Dopaminergic Control of Prolactin Release
Ojeda, S. R., Harms, P. G., & McCann, S. M. (1974) · Endocrinology · doi:10.1210/endo-95-6-1694 · Cited by 70
Melkersson, K. I. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.811 · Cited by 69
Bagdy, G., & Makara, G. B. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00051-l · Cited by 51
Prolactin: A Hormone at the Crossroads of Neuroimmunoendocrinology
Goffin, V., Bouchard, B., Ormandy, C. J., Weimann, E., Ferrag, F., Touraine, P. A., Bôle‐Feysot, C., Maaskant, R. A., Clément-Lacroix, P., Edery, M., et al. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09588.x · Cited by 50
Arita, J., Kojima, Y., & Kimura, F. (1991) · Endocrinology · doi:10.1210/endo-128-4-1887 · Cited by 47
Further analysis of presence of peptides in dopamine neurons
Seroogy, K. B., Tsuruo, Y., H�kfelt, T., Walsh, J. H., Fahrenkrug, J., Emson, P. C., & Goldstein, M. (1988) · Experimental Brain Research · doi:10.1007/bf00250598 · Cited by 47
Enjalbert, A., Guillon, G., Mouillac, B., Audinot, V., Rasolonjanahary, R., Kordon, C., & Bockaert, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30586-0 · Cited by 46
Johnston, C. A., & Negro-Vilar, A. F. (1986) · Endocrinology · doi:10.1210/endo-118-2-797 · Cited by 42
Estradiol Attenuates the Forskolin-Induced Increase in HypothalamicTyrosine Hydroxylase Activity
Arbogast, L. A., & Hyde, J. F. (2000) · Neuroendocrinology · doi:10.1159/000054539 · Cited by 40
Durham, R. A., Eaton, M. J., Moore, K. E., & Lookingland, K. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01179-5 · Cited by 33
Merchenthaler, I. J., Lennard, D. E., Cianchetta, P., Merchenthaler, A., & Bronstein, D. M. (1995) · Endocrinology · doi:10.1210/endo.136.6.7750466 · Cited by 31
Dopaminergíc Mediation of β-Endorphin-Induced Prolactin Secretion
Loon, G. R. V., Souza, E. B. D., & Shin, S. H. (2008) · Neuroendocrinology · doi:10.1159/000123091 · Cited by 31
Oestrogen, Progesterone and Serotonin Converge on GABAergic Neurones in the Monkey Hypothalamus
Mirkes, S. J., & Bethea, C. L. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00612.x · Cited by 30
Papageorgiou, A., & Denef, C. (2006) · Endocrinology · doi:10.1210/en.2006-1198 · Cited by 29
NEUROENDOCRINE CONTROL OF PROLACTIN IN EXPERIMENTAL ANIMALS
Meites, J. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb03334.x · Cited by 28
ENDOCRINE EFFECTS OF DOMPERIDONE: A PERIPHERAL DOPAMINE BLOCKING AGENT
Brown, G. M., VERHAEGAN, H., Greidanus, T. B. V. W., et al. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00666.x · Cited by 27
Physiological Significance of the Negative Short-Loop Feedback of Prolactin
Milenković, L., Parlow, A. F., & McCann, S. M. (2008) · Neuroendocrinology · doi:10.1159/000125610 · Cited by 27
Pasqualini, C., Bojda, F., Gaudoux, F., Guibert, B., Leviel, V., Teissier, E., Rips, R., & Kerdelhué, B. (2008) · Neuroendocrinology · doi:10.1159/000125029 · Cited by 26
Tachykinins and the control of prolactin secretion
Debéljuk, L., & Lasaga, M. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.010 · Cited by 25
de Kar, L. D. V., Lorens, S. A., Urban, J. H., Richardson, K. D., Paris, J. M., & Bethea, C. L. (1985) · Brain Research · doi:10.1016/0006-8993(85)91001-7 · Cited by 23
Durham, R. A., Johnson, J. D., Eaton, M. J., Moore, K. E., & Lookingland, K. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00498-1 · Cited by 21
D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
Berry, S. A., & Gudelsky, G. A. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12673-6 · Cited by 19
Eaton, M. J., Gopalan, C., Kim, E., Lookingland, K. J., & Moore, K. E. (1993) · Brain Research · doi:10.1016/0006-8993(93)90480-b · Cited by 17
Lledo, P., Israël, J. M., & Vincent, J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90773-o · Cited by 15
371. Transient d2 dopamine receptor occupancy in low EPS-incidence drugs: PET evidence
Jones, C. E., Kapur, S., Remington, G. J., & Zipursky, R. B. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00635-1 · Cited by 11
Involvement of hypothalamic substance P in the effect of prolactin on dopamine release
Isovich, E., Dı́az, M. D. C., Lasaga, M., Pisera, D. A., Zambruno, C., Theas, M. S., Seilicovich, A., & Duvilanski, B. H. (1994) · Neuroreport · doi:10.1097/00001756-199409080-00016 · Cited by 9
Cited by
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism
García-Cáceres, C., Balland, E., Prevot, V., Luquet, S., Woods, S. C., Koch, M., Horvath, T. L., Yi, C.-X., Chowen, J. A., Verkhratsky, A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0286-y · Cited by 329
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Rosenfeld, C. S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24603 · Cited by 280
O'Keane, V. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088439 · Cited by 126
Metadata
- Authors
- Fitzgerald, P., & Dinan, T. G.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-03
- Volume
- 22
- Issue
- 2_suppl
- Pages
- 12-19
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2166604754
- Cited by
- 383
- References
- 81
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.